Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06891638 · ClinicalTrials.gov registry record · NA
Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy
A NA study, sponsored by Kessler Foundation.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT06891638: Completed NA study, sponsored by Kessler Foundation.
NCT06891638 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06891638, a NA study, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is designed for individuals with aphasia, a language disorder that affects many stroke survivors, making it difficult to read, speak, and understand language. Up to 70% of people with aphasia struggle with reading, which impacts their ability to communicate, work, and engage in daily life. The study aims to test a new approach to reading rehabilitation by combining Phono-Motor Treatment (PMT), a language therapy adapted to improve reading, with transcranial direct current stimulation (tDCS), a safe and painless brain stimulation technique. tDCS delivers a mild electrical current to the brain, which may enhance learning. This study will assess whether adding tDCS to PMT improves reading therapy outcomes.
Primary Outcome
Participants will read words and pronounceable pseudowords that appear one at a time on the computer screen. Each testing session will be audio recorded and independently scored by 2 raters, with ties resolved by a 3rd rater.
Interventions
- DEVICE Schedule of tDCS administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-05-12 |
| Est. Completion | 2026-02-14 |
| Phase | NA |
What the finished NCT06891638 record still lists
NCT06891638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Schedule of tDCS administration is the first listed.
NCT06891638 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06891638 about?
NCT06891638 is a clinical study titled "Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy". This study is designed for individuals with aphasia, a language disorder that affects many stroke survivors, making it difficult to read, speak, and understand language. Up to 70% of people with aphasia struggle with reading, which impacts their ability to communicate, work, and engage in daily life...
What is the current status of trial NCT06891638?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2025-05-12. Estimated completion is 2026-02-14.
What interventions are being tested in trial NCT06891638?
The interventions under investigation include: Schedule of tDCS administration (DEVICE).
Who is sponsoring clinical trial NCT06891638?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06891638's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI